Whitehawk Therapeutics (WHWK) Interest Expenses (2010 - 2024)
Whitehawk Therapeutics (WHWK) reported Interest Expenses of $38000.0 for Q3 2024, down 34.48% year-over-year from $58000.0 in Q4 2023, and down 34.48% quarter-over-quarter from $58000.0 in Q2 2024.
Whitehawk Therapeutics (WHWK) Interest Expenses (2010 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 12 years of Interest Expenses data on file, last reported at $38000.0 in Q3 2024.
- Interest Expenses for Q3 2024 came in at $38000.0, down 34.48% year-over-year; the trailing twelve-month figure through Jun 2025 was $38000.0 (down 83.55% YoY), and the FY2024 annual result was $154000.0, down 33.33% from the prior year.
- Interest Expenses slipped to $38000.0 in Q3 2024 per WHWK's latest filing, from $58000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $284000.0 in Q4 2020 and troughed at $38000.0 in Q3 2024.
- A 5-year average of $105529.4 and a median of $58000.0 in 2022 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2021 and 2022: Interest Expenses tumbled 79.93% in 2021, then changed 0.0% in 2022.
- A 5-year view of Interest Expenses shows it stood at $284000.0 in 2020, then slumped by 79.93% to $57000.0 in 2021, then changed by 0.0% to $57000.0 in 2022, then changed by 0.0% to $57000.0 in 2023, then tumbled by 33.33% to $38000.0 in 2024.
- Business Quant data shows WHWK's Interest Expenses at $38000.0 in Q3 2024, $58000.0 in Q2 2024, and $58000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 38,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Jun 30, 2023 | 58,000.00 |
| Jun 30, 2023 | 58,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Dec 31, 2022 | 57,000.00 |
| Dec 31, 2022 | 57,000.00 |
| Sep 30, 2022 | 58,000.00 |
| Sep 30, 2022 | 58,000.00 |
| Jun 30, 2022 | 58,000.00 |
| Jun 30, 2022 | 58,000.00 |